Glenmede Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,743	Closed	-$919K	–	1376
2024 Q4	$919K	Sell	24,743 -13,141	-35%	-$601K	﹤0.01%	748
2024 Q3	$1.84M	Buy	37,884 +22,439	+145%	+$985K	0.01%	583
2024 Q2	$618K	Sell	15,445 -1,591	-9%	-$65.9K	﹤0.01%	825
2024 Q1	$748K	Sell	17,036 -1,080	-6%	-$55.8K	﹤0.01%	791
2023 Q4	$1.12M	Buy	18,116 +7,672	+73%	+$403K	0.01%	661
2023 Q3	$480K	Sell	10,444 -27	-0.3%	-$1.47K	﹤0.01%	854
2023 Q2	$393K	Hold	10,471	–	–	﹤0.01%	901
2023 Q1	$393K	Sell	10,471 -29	-0.3%	-$951	﹤0.01%	906
2022 Q4	$294K	Sell	10,500 -365	-3%	-$10.6K	﹤0.01%	989
2022 Q3	$305K	Buy	10,865 +318	+3%	+$10.4K	﹤0.01%	954
2022 Q2	$366K	Buy	+10,547	New	+$376K	﹤0.01%	948
2020 Q4	–	Sell	-104	Closed	-$1K	–	1241
2020 Q3	$1K	Sell	104 -98	-49%	-$1.97K	﹤0.01%	2317
2020 Q2	$4K	Sell	202 -474	-70%	-$8.68K	﹤0.01%	2108
2020 Q1	$13K	Hold	676	–	–	﹤0.01%	2290
2019 Q4	$13K	Buy	676 +131	+24%	+$2.51K	﹤0.01%	2290
2019 Q3	$10	Sell	545 -10	-2%	-$208	﹤0.01%	2335
2019 Q2	$11	Sell	555 -42	-7%	-$878	﹤0.01%	2324
2019 Q1	$12	Hold	597	–	–	﹤0.01%	2285
2018 Q4	$11	Buy	+597	New	+$11.8K	﹤0.01%	2223